These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28045139)

  • 1. Chrna7 deficient mice manifest no consistent neuropsychiatric and behavioral phenotypes.
    Yin J; Chen W; Yang H; Xue M; Schaaf CP
    Sci Rep; 2017 Jan; 7():39941. PubMed ID: 28045139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human clinical phenotypes of altered CHRNA7 copy number.
    Gillentine MA; Schaaf CP
    Biochem Pharmacol; 2015 Oct; 97(4):352-362. PubMed ID: 26095975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Cognitive and Behavioral Phenotypes of Individuals with CHRNA7 Duplications.
    Gillentine MA; Berry LN; Goin-Kochel RP; Ali MA; Ge J; Guffey D; Rosenfeld JA; Hannig V; Bader P; Proud M; Shinawi M; Graham BH; Lin A; Lalani SR; Reynolds J; Chen M; Grebe T; Minard CG; Stankiewicz P; Beaudet AL; Schaaf CP
    J Autism Dev Disord; 2017 Mar; 47(3):549-562. PubMed ID: 27853923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction between maternal immune activation and alpha 7 nicotinic acetylcholine receptor in regulating behaviors in the offspring.
    Wu WL; Adams CE; Stevens KE; Chow KH; Freedman R; Patterson PH
    Brain Behav Immun; 2015 May; 46():192-202. PubMed ID: 25683697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Consequences of CHRNA7 Copy-Number Alterations in Induced Pluripotent Stem Cells and Neural Progenitor Cells.
    Gillentine MA; Yin J; Bajic A; Zhang P; Cummock S; Kim JJ; Schaaf CP
    Am J Hum Genet; 2017 Dec; 101(6):874-887. PubMed ID: 29129316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 15q13.3 deletion syndrome: Deficient α(7)-containing nicotinic acetylcholine receptor-mediated neurotransmission in the pathogenesis of neurodevelopmental disorders.
    Deutsch SI; Burket JA; Benson AD; Urbano MR
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():109-17. PubMed ID: 26257138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An acetylcholine alpha7 positive allosteric modulator rescues a schizophrenia-associated brain endophenotype in the 15q13.3 microdeletion, encompassing CHRNA7.
    Gass N; Weber-Fahr W; Sartorius A; Becker R; Didriksen M; Stensbøl TB; Bastlund JF; Meyer-Lindenberg A; Schwarz AJ
    Eur Neuropsychopharmacol; 2016 Jul; 26(7):1150-60. PubMed ID: 27061851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CHRNA7 Deletions are Enriched in Risperidone-Treated Children and Adolescents.
    Gillentine MA; White JJ; Grochowski CM; Lupski JR; Schaaf CP; Calarge CA
    J Child Adolesc Psychopharmacol; 2017 Dec; 27(10):908-915. PubMed ID: 28817303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of CHRNA7 rare variants in autism spectrum disorder susceptibility.
    Bacchelli E; Battaglia A; Cameli C; Lomartire S; Tancredi R; Thomson S; Sutcliffe JS; Maestrini E
    Am J Med Genet A; 2015 Apr; 167A(4):715-23. PubMed ID: 25655306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of single gene deletions at 15q13.3: further evidence that CHRNA7 causes the 15q13.3 microdeletion syndrome phenotype.
    Hoppman-Chaney N; Wain K; Seger PR; Superneau DW; Hodge JC
    Clin Genet; 2013 Apr; 83(4):345-51. PubMed ID: 22775350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CHRNA7 triplication associated with cognitive impairment and neuropsychiatric phenotypes in a three-generation pedigree.
    Soler-Alfonso C; Carvalho CM; Ge J; Roney EK; Bader PI; Kolodziejska KE; Miller RM; Lupski JR; Stankiewicz P; Cheung SW; Bi W; Schaaf CP
    Eur J Hum Genet; 2014 Sep; 22(9):1071-6. PubMed ID: 24424125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered neuronal physiology, development, and function associated with a common chromosome 15 duplication involving CHRNA7.
    Meganathan K; Prakasam R; Baldridge D; Gontarz P; Zhang B; Urano F; Bonni A; Maloney SE; Turner TN; Huettner JE; Constantino JN; Kroll KL
    BMC Biol; 2021 Jul; 19(1):147. PubMed ID: 34320968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Phenotypic Spectrum of 15q13.3 Region Duplications: Report of 5 Patients.
    Budisteanu M; Papuc SM; Streata I; Cucu M; Pirvu A; Serban-Sosoi S; Erbescu A; Andrei E; Iliescu C; Ioana D; Severin E; Ioana M; Arghir A
    Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mouse model that recapitulates cardinal features of the 15q13.3 microdeletion syndrome including schizophrenia- and epilepsy-related alterations.
    Fejgin K; Nielsen J; Birknow MR; Bastlund JF; Nielsen V; Lauridsen JB; Stefansson H; Steinberg S; Sorensen HB; Mortensen TE; Larsen PH; Klewe IV; Rasmussen SV; Stefansson K; Werge TM; Kallunki P; Christensen KV; Didriksen M
    Biol Psychiatry; 2014 Jul; 76(2):128-37. PubMed ID: 24090792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensorimotor gating and spatial learning in α7-nicotinic receptor knockout mice.
    Azzopardi E; Typlt M; Jenkins B; Schmid S
    Genes Brain Behav; 2013 Jun; 12(4):414-23. PubMed ID: 23521765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHRNA7 copy number gains are enriched in adolescents with major depressive and anxiety disorders.
    Gillentine MA; Lozoya R; Yin J; Grochowski CM; White JJ; Schaaf CP; Calarge CA
    J Affect Disord; 2018 Oct; 239():247-252. PubMed ID: 30029151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maximizing the effect of an α7 nicotinic receptor PAM in a mouse model of schizophrenia-like sensory inhibition deficits.
    Stevens KE; Zheng L; Floyd KL; Stitzel JA
    Brain Res; 2015 Jun; 1611():8-17. PubMed ID: 25744161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced Chrna7 expression in mice is associated with decreases in hippocampal markers of inhibitory function: implications for neuropsychiatric diseases.
    Adams CE; Yonchek JC; Schulz KM; Graw SL; Stitzel J; Teschke PU; Stevens KE
    Neuroscience; 2012 Apr; 207():274-82. PubMed ID: 22314319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mice with mutations in Trpm1, a gene in the locus of 15q13.3 microdeletion syndrome, display pronounced hyperactivity and decreased anxiety-like behavior.
    Hori T; Ikuta S; Hattori S; Takao K; Miyakawa T; Koike C
    Mol Brain; 2021 Mar; 14(1):61. PubMed ID: 33785025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular, physiological and behavioral characterization of the heterozygous Df[h15q13]/+ mouse model associated with the human 15q13.3 microdeletion syndrome.
    Rees KA; Halawa AA; Consuegra-Garcia D; Golub VM; Clossen BL; Tan AM; Montgomery KS; Samba Reddy D; Griffith WH; Winzer-Serhan UH
    Brain Res; 2020 Nov; 1746():147024. PubMed ID: 32712126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.